Insomnia Outcomes May Vary by Measurement Method  - Takeaways - MDSpire

Insomnia Outcomes May Vary by Measurement Method 

Smartphone-based symptom tracking highlights gaps in how insomnia treatments are evaluated.

  • By

  • Henry Thomas

  • February 12, 2026

  • 3 min

Share

  • 1

    Standard patient-reported outcome measures may overlook daytime effects of insomnia pharmacotherapy.

  • 2

    A randomized trial showed suvorexant improved insomnia severity but revealed time-of-day effects on fatigue and cognition using smartphone-based EMA.

  • 3

    Participants treated with suvorexant experienced greater morning fatigue and reduced alertness earlier in the day compared to placebo.

  • 4

    EMA demonstrated significant treatment-related differences in daytime symptoms, highlighting its feasibility in older adults.

  • 5

    The study suggests broader EMA adoption could enhance insomnia therapy evaluations and support patient-centered treatment decisions.

Original Source(s)

Insomnia Outcomes May Vary by Measurement Method 

  • by Henry Thomas

  • February 12, 2026

Related Content

Physicians Exiting Practice Earlier

Researchers identify burnout-associated workplace pressures and caregiving responsibilities as major contributors to physician attrition.

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

When minds and networks matter: how mental health and social capital shape social frailty in older adults